211 related articles for article (PubMed ID: 15194759)
1. Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency.
McClellan JS; Tibbetts SA; Gangappa S; Brett KA; Virgin HW
J Virol; 2004 Jul; 78(13):6836-45. PubMed ID: 15194759
[TBL] [Abstract][Full Text] [Related]
2. Effective vaccination against long-term gammaherpesvirus latency.
Tibbetts SA; McClellan JS; Gangappa S; Speck SH; Virgin HW
J Virol; 2003 Feb; 77(4):2522-9. PubMed ID: 12551990
[TBL] [Abstract][Full Text] [Related]
3. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.
Sparks-Thissen RL; Braaten DC; Kreher S; Speck SH; Virgin HW
J Virol; 2004 Jul; 78(13):6827-35. PubMed ID: 15194758
[TBL] [Abstract][Full Text] [Related]
4. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.
Braaten DC; Sparks-Thissen RL; Kreher S; Speck SH; Virgin HW
J Virol; 2005 Feb; 79(4):2573-83. PubMed ID: 15681457
[TBL] [Abstract][Full Text] [Related]
5. Requirement for CD4+ T cells in V beta 4+CD8+ T cell activation associated with latent murine gammaherpesvirus infection.
Flaño E; Woodland DL; Blackman MA
J Immunol; 1999 Sep; 163(6):3403-8. PubMed ID: 10477611
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation.
Jacoby MA; Virgin HW; Speck SH
J Virol; 2002 Feb; 76(4):1790-801. PubMed ID: 11799175
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against murine gamma-herpesvirus infection.
Woodland DL; Usherwood EJ; Liu L; Flaño E; Kim IJ; Blackman MA
Viral Immunol; 2001; 14(3):217-26. PubMed ID: 11572633
[TBL] [Abstract][Full Text] [Related]
8. Natural history of murine gamma-herpesvirus infection.
Nash AA; Dutia BM; Stewart JP; Davison AJ
Philos Trans R Soc Lond B Biol Sci; 2001 Apr; 356(1408):569-79. PubMed ID: 11313012
[TBL] [Abstract][Full Text] [Related]
9. LXR Alpha Restricts Gammaherpesvirus Reactivation from Latently Infected Peritoneal Cells.
Lange PT; Jondle CN; Darrah EJ; Johnson KE; Tarakanova VL
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602604
[TBL] [Abstract][Full Text] [Related]
10. Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.
Gangappa S; Kapadia SB; Speck SH; Virgin HW
J Virol; 2002 Nov; 76(22):11460-8. PubMed ID: 12388707
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cells loaded with tumor B cells elicit broad immunity against murine gammaherpesvirus 68 but fail to prevent long-term latency.
Weslow-Schmidt J; Ye F; Cush SS; Stuller KA; Blackman MA; Flaño E
J Virol; 2010 Sep; 84(17):8975-9. PubMed ID: 20592077
[TBL] [Abstract][Full Text] [Related]
12. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus.
Sarawar SR; Lee BJ; Reiter SK; Schoenberger SP
Proc Natl Acad Sci U S A; 2001 May; 98(11):6325-9. PubMed ID: 11353832
[TBL] [Abstract][Full Text] [Related]
13. CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma.
Sparks-Thissen RL; Braaten DC; Hildner K; Murphy TL; Murphy KM; Virgin HW
Virology; 2005 Aug; 338(2):201-8. PubMed ID: 15961135
[TBL] [Abstract][Full Text] [Related]
14. Latent antigen vaccination in a model gammaherpesvirus infection.
Usherwood EJ; Ward KA; Blackman MA; Stewart JP; Woodland DL
J Virol; 2001 Sep; 75(17):8283-8. PubMed ID: 11483773
[TBL] [Abstract][Full Text] [Related]
15. Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection.
Aricò E; Robertson KA; Belardelli F; Ferrantini M; Nash AA
Vaccine; 2004 Mar; 22(11-12):1433-40. PubMed ID: 15063566
[TBL] [Abstract][Full Text] [Related]
16. A replication-deficient murine gamma-herpesvirus blocked in late viral gene expression can establish latency and elicit protective cellular immunity.
Kayhan B; Yager EJ; Lanzer K; Cookenham T; Jia Q; Wu TT; Woodland DL; Sun R; Blackman MA
J Immunol; 2007 Dec; 179(12):8392-402. PubMed ID: 18056385
[TBL] [Abstract][Full Text] [Related]
17. Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses.
McClellan KB; Gangappa S; Speck SH; Virgin HW
PLoS Pathog; 2006 Jun; 2(6):e58. PubMed ID: 16789842
[TBL] [Abstract][Full Text] [Related]
18. Absence of splenic latency in murine gammaherpesvirus 68-infected B cell-deficient mice.
Usherwood EJ; Stewart JP; Robertson K; Allen DJ; Nash AA
J Gen Virol; 1996 Nov; 77 ( Pt 11)():2819-25. PubMed ID: 8922476
[TBL] [Abstract][Full Text] [Related]
19. Reduced functional capacity of CD8+ T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice.
Liu H; Andreansky S; Diaz G; Hogg T; Doherty PC
J Immunol; 2002 Apr; 168(7):3477-83. PubMed ID: 11907108
[TBL] [Abstract][Full Text] [Related]
20. Gamma interferon blocks gammaherpesvirus reactivation from latency in a cell type-specific manner.
Steed A; Buch T; Waisman A; Virgin HW
J Virol; 2007 Jun; 81(11):6134-40. PubMed ID: 17360749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
